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Malignant hyperthermia (MH) is a chain reaction of
symptoms that is triggered in susceptible individuals by
commonly used inhalation agents such as halothane,
enflurane and isoflurane, and the muscle relaxant
succinylcholine. The symptoms include a greatly increased
body metabolism, muscle rigidity and high fever. During
sevoflurane anesthesia, we encountered a case of MH,
which was successfully treated by symptomatic
treatment.

Case Report
A 23-year-old, 55-kg man was scheduled for
nasoplasty because of septonasal deformity. Neither the
patient nor his family had any history of neuromuscular
disease, and he had not received general anesthesia
previously. Preoperative laboratory examinations were
within normal values.
The patient did not receive premedication. Anesthesia
was induced with the intravenous administration of
thiopental (500 mg), fentanyl (50 µg) and vecuronium (8
mg), and an 8.5 mm tracheal tube was inserted without
any difficulty under direct laryngoscopy. Anesthesia was
maintained with sevoflurane 1.5-2% in 65% nitrous
oxide/35% oxygen at a flow rate of approximately 4 and
2 L/min, respectively. Standard monitoring was used, but
end-tidal CO2 was not monitored during anesthesia in this
case because no capnograph was available. Before
induction of anesthesia, heart rate and systolic/diastolic
blood pressure were 94 beats per minute and 110/80
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mmHg. Rectal temperature after the induction of
anesthesia was 36.9ºC. One hundred ten minutes after
induction, adrenaline (4 ml, 1:200000) and prilocaine (4
ml, 2%) were injected submucosally by the surgeon to
reduce bleeding and for early postoperative pain relief.
Vital signs remained stable for 120 minutes after
induction when the patient suddenly developed a
tachycardia of 148 beats per minute. The increasing heart
rate was considered to be due to local anesthetic
containing adrenaline, but rectal temperature also
increased dramatically, from 36.9 to 39.9ºC in 15
minutes, and profuse sweating was noted. There was
marked skeletal muscle rigidity of the upper and lower
extremities. Soda lime absorber was noted to be hot, and
its color changed to purple. We concluded that malignant
hyperthermia had developed; sevoflurane and nitrous
oxide were discontinued, and 100% oxygen was
administered through the same anesthetic circuit at a high
flow rate (12 L/min). The operation was terminated as
soon as possible, and active cooling was immediately
initiated by ice water. A 16-gauge femoral venous and a
20-gauge right arterial catheter were inserted. At that
time, pH was 7.15, PaO2 479 mmHg, PaCO2 64 mmHg,
base excess -9 mmol/L, and potassium 4.3 mEq/L. Severe
hypercarbia was in no way associated with rebreathing or
inadequate ventilation. Sodium bicarbonate, verapamil,
methyl prednisolone and insulin-5% dextrose solution
were administered intravenously. Furosemide and 20%
mannitol infusion were given for adequate urine output.
Midazolam was given for sedation. Muscle rigidity
improved slowly over the next 50 minutes. During active
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cooling, ventricular tachycardia of five seconds duration
developed, and bolus dose lidocaine was given initially,
followed by infusion. When the rectal temperature
decreased to 38.5ºC, active cooling was terminated.
Approximately 2 hours after the onset of MH, the patient
was responsive and demonstrated adequate muscle
strength, and the trachea was extubated. Analysis of
arterial blood revealed a pH of 7.39, PaCO2 54 mmHg,
PaO2 115 mmHg, base excess +6 mmol/L, and potassium
3.6 mEq/L. The patient was transferred to the intensive
care unit for further observation. Dantrolene was not
administered, as it was not available when the attack
developed. The serum creatine phosphokinase level
reached a maximum value of 4138 IU/L at the 24th
postoperative hour and began to decrease on the second
postoperative day. The blood myoglobin concentration
was >405 ng/mL at the fifth postoperative hour, and
returned to normal on the second postoperative day. The
postoperative period was uneventful and the patient was
discharged from the hospital five days after the
operation.
Three factors may have contributed to the rapid rise
in temperature seen in our patient: sevoflurane,
prilocaine and adrenaline. It was previously believed that
amide local anesthetics could trigger MH (1). Support for
this hypothesis was provided by a report of an MH
episode occurring during epidural anesthesia with
lidocaine, suggesting that the amide local anesthetics in
large doses might trigger MH (2). On the other hand, in
inbred swine, MH is not triggered even with enormous
doses of intravenous lidocaine (3). In addition, another
amide local anesthetic, prilocaine, has been used for the
contracture test under 3-in 1 lumbar plexus blockade for
the diagnosis of MH in several studies, and it was
suggested that prilocaine is a safe drug in MH susceptible
patients (4). Finally, amide local anesthetics are now
routinely used for nerve blockade anesthesia in MH
susceptible patients undergoing muscle biopsy, without
untoward events. In our patient, we also used prilocaine
and lidocaine, amide local anesthetics, for postoperative
analgesia and treatment of MH in ventricular tachycardia
attack, respectively. We believe that neither of these
agents was responsible for the development of MH in our
patient, as prilocaine is a safe agent and lidocaine was
used in low doses.
It has been suggested that sympathetic activity
contributes to fulminant MH syndrome (5). In our case,
adrenaline administration 10 minutes prior to the MH
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crisis might have been the initiating agent. However, it
has been shown that continuous intravenous infusion of
noradrenaline in pigs in blood concentrations of as high as
140 ng/ml did not mediate or initiate the porcine whole
body stress response characteristic of MH (6). At present,
it is widely accepted that adrenaline is a safe drug for MH
susceptible patients and therefore is an unlikely candidate
for the initiating agent in our patient.
Shulman et al. reported that sevoflurane triggered
MH in MH susceptible swine, but the relationship
between MH and sevoflurane is not well defined in
humans (7). The onset of MH with sevoflurane in humans
has been reported to occur both at an early period and
after prolonged anesthesia (8). In our patient, the MH
crisis developed 2 h after inhalation of sevoflurane, and
we believe that in the present case the initiating agent
was sevoflurane. The symptoms in our case were mild
and did not persist after sevoflurane discontinuation, and,
despite the unavailability of dantrolene, responded well to
symptomatic treatment. There are five case reports in
which benign sevoflurane induced MH occurred and was
treated with dantrolene.
Dantrolene inhibits intracellular calcium release by the
sarcoplasmic reticulum and dissociates excitationcontraction in muscle cells. Although intravenous
administration of dantrolene is a specific therapeutic
agent for MH, we were not able to use dantrolene
because it was not available in the early stage. Dantrolene
was obtained eight hours after the occurrence of MH but,
since the patient recovered, it was not used. To the best
of our knowledge there has been no previous report of
sevoflurane-induced MH treated without dantrolene.
Calcium channel blockers such as verapamil are not
recommended in MH crises since hyperkalemia may occur
with the dantrolene-verapamil combination, as has been
previously reported in both animals and humans (10).
However, San Juan et al. showed in an animal model that
the increase in potassium could be totally attributed to
intravenous dantrolene alone (10). As no dantrolene was
administered to our patient, we used verapamil for
supraventricular tachycardia, and the peak serum
potassium level did not exceed 4.3 mmol/L.
This case report shows that MH triggered by
sevoflurane is mild. Although dantrolene is essential for
the management of MH, when it is unavailable, mild MH
may be treated with vigorous management of symptoms.
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